Seminar of the KG Jebsen Center for Cancer Immunotherapy, co-hosted by Oslo Cancer Cluster   Speaker: Bob Valamehr, Vice President, Cancer Immunotherapy at Fate Therapeutics Inc Moderator: Kalle Malmberg, KG Jebsen Center for Cancer Immunotherapy   Program will be available soon. Here is the invitation: KG Jebsen Seminar_FEb 17th  

The KG Jebsen Institute for Cancer Immunotherapy cordially invites you to an exciting talk given by Markwin Velders from Kite Pharma. Welcome to an exciting one hour seminar about Kite’s route to advance T-cell therapy to the market. The meeting will take place in the auditorium of the research building at Radiumhospitalet, Oslo. Kite Pharma […]

Legemiddelindustrien (LMI) and partners invite you to Partnership for life. As part of the Oslo Life Science Conference 11-14 February 2019, LMI arranges the event Partnership for life in collaboration with Astra Zeneca, AbbVie, Bayer, GE Healthcare and Pfizer, and the clusters Oslo Cancer Cluster, Nansen Neuroscience Network and The Life Science Cluster. To register and […]

This breakfast seminar is organised by the UiO:Life Science project Personalized Cancer Therapy (PerCaThe). It will discuss the future development of Cancer Precision Medicine and specifically how the field can move to implementation in clinical trials and next in clinical practice. Programme: 0730–0800 Breakfast Foyer / Mingling area, Ground Floor, Research Building, OUH Radiumhospitalet 0800–0805 Welcome and […]

Cell-Based Cancer Immunotherapy (STRAT-CELL) is a novel strategic research area at OUH with an overarching goal to fast-track the clinical implementation of new strategies for gene-editing of cytotoxic lymphocytes. The initiative will operate at the interface between academia and industry and support a clinical pipe-line of investigator-initiated trials. We want to welcome you all to […]